| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | — | -3.8% |
| Cost of Revenue | $931K | — | +7.8% |
| Gross Profit | $948K | — | -13.0% |
| R&D Expense | $298K | — | +80.6% |
| SG&A Expense | $3.3M | — | +69.3% |
| Operating Income | -$3.0M | — | -130.6% |
| Pre-tax Income | -$868K | — | -243.1% |
| Income Tax | $4K | — | — |
| Net Income | -$872K | — | +57.7% |
| EPS (Basic) | -$0.03 | — | +0.0% |
| EPS (Diluted) | -$0.03 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.8M | -58.0% | — |
| Accounts Receivable | $1.2M | -1.7% | — |
| Current Assets | $3.7M | -40.2% | — |
| Total Assets | $4.9M | -34.4% | — |
| Current Liabilities | $18.1M | -9.6% | — |
| Long-term Debt | $300K | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | — | -871.2% |
| Capital Expenditures | $20K | — | +1900.0% |
| Investing Cash Flow | -$56K | — | -133.3% |
| Financing Cash Flow | -$174K | — | -196.7% |
| Free Cash Flow | -$2.2M | — | -875.7% |
| Total Liabilities | $20.0M | -9.7% | — |
| Stockholders' Equity | -$15.0M | -3.1% | -34.6% |